covid 19 News and Research

RSS

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

AI tool effectively detects distress in hospital workers' conversations

An artificial intelligence tool effectively detected distress in hospital workers' conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.

24 Oct 2023

Engineered bacteria could offer new treatment for hypertension

Scientists at The University of Toledo have proven that engineered bacteria can lower blood pressure, a finding that opens new doors in the pursuit of harnessing our body's own microbiome to treat hypertension.

24 Oct 2023

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

24 Oct 2023

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

At the height of the COVID-19 pandemic, Virginia Tech disease ecologists wondered if the virus was having the same effect on wildlife.

24 Oct 2023

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

While breast cancer survival continues to improve, thanks to advances in detection and treatment, when breast cancer recurs – or returns after initial treatment – it is incurable.

24 Oct 2023

Research suggests shorter isolation periods for children with COVID-19

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

24 Oct 2023

Weakened innate immunity may increase risk of severe COVID-19

During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection.

24 Oct 2023

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

24 Oct 2023

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

The decline in neutralizing antibody (nAb) titers following COVID-19 vaccination.

24 Oct 2023

Genomic surveillance could help detect and slow the spread of deadly 'superbugs'

Harnessing new advances in genomic surveillance technology could help detect the rise of deadly 'superbugs' and slow their evolution and spread, improving global health outcomes, a new Australian study suggests.

24 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Deep-learning models predict COVID-19 cases globally with high accuracy

An AI deep learning model to predict the number of COVID-19 cases 14 days into the future.

24 Oct 2023

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

A single-dose intranasal vaccine effectively induces robust immune responses.

24 Oct 2023

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Healthcare utilization by long coronavirus disease (COVID) or LC patients between January 2020 and 2023.

24 Oct 2023

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

Research paper evaluates the mental health impacts of the first COVID-19 wave on U.K. residents, revealing heightened psychological distress particularly among younger people, women, and minority groups. Factors such as financial stress, loneliness, and household density were found to significantly influence the severity of mental health decline during the pandemic.

23 Oct 2023

New insights into why obesity puts individuals at risk for severe influenza

The mechanisms underpinning severe cases of influenza among the obese population.

23 Oct 2023

Metacognition and the pandemic: how our beliefs influence our choices

The ability to self-reflect upon one's beliefs and behavior, during the coronavirus disease 2019 (COVID-19) pandemic.

23 Oct 2023

covid 19 News and Research

Kids with Omicron non-infectious after three days, vaccination status irrelevant

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

AI tool effectively detects distress in hospital workers' conversations

Engineered bacteria could offer new treatment for hypertension

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

Research suggests shorter isolation periods for children with COVID-19

Weakened innate immunity may increase risk of severe COVID-19

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Genomic surveillance could help detect and slow the spread of deadly 'superbugs'

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Deep-learning models predict COVID-19 cases globally with high accuracy

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Is COVID-19 a risk factor for Alzheimer's disease?

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

New insights into why obesity puts individuals at risk for severe influenza

Metacognition and the pandemic: how our beliefs influence our choices

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News